Infusing Rhenium NanoLiposomes into Glioblastoma Showing High Efficacy in Eradicating Brain Tumors

Updated: May 27

An Empowered Patient Podcast at Medical and Pharma Insider hosted by Karen Jagoda


Dr. Marc Hedrick, President and CEO of PLUS Therapeutics describes the challenges of fighting brain cancers like glioblastoma.


The PLUS lead investigational asset Rhenium NanoLiposome (RNL) delivers radiation directly to the tumor using a method called Convection Enhanced Delivery. This approach allows the neurosurgeon to put catheters directly into the brain by using stereotactic brain biopsy, imaging and software driven planning bypassing the normal structures and delivering 20 or more times the amount of radiation than can be delivered by external beam radiation.


Listen to Podcast


Podcast Transcript